KKR funds to buy clinical trial firm PRA International
(Reuters) - Funds managed by KKR & Co LP will buy clinical research group PRA International from Genstar Capital LLC for an undisclosed amount, PRA said on Monday, underscoring growing private equity interest in the contract research industry. Sources familiar with the matter had previously told Reuters that PRA could be worth as much as $1.3 billion. The deal comes at a time when research service firms are either being snapped up by private equity firms or are being taken public. ...
No comments:
Post a Comment